Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsTOPICALStandard

CONDYLOX

PODOFILOX

Standard Dose
0.5%
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Prescription
Summary

Approval overview CONDYLOX is listed in Drugs@FDA under application 019795 (NDA).

Review priority: PRIORITY Marketing status: Prescription Active ingredient PODOFILOX Form and strength SOLUTION;TOPICAL - 0.5% Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2015-10-30 00:00:00.

Structured Monograph

Clinical summary

Approval overview CONDYLOX is listed in Drugs@FDA under application 019795 (NDA). Review priority: PRIORITY Marketing status: Prescription Active ingredient PODOFILOX Form and strength SOLUTION;TOPICAL - 0.5% Sponsor TEVA BRANDED PHARM Submission history Latest submission status date: 2015-10-30 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: PRIORITY

Interaction Notes

  • No interaction notes stored yet.